FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

34963811000001100: Co-careldopa 25mg/100mg tablets 50 tablet (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 27-Dec 2017. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
106003301000001116 Co-careldopa 25mg/100mg tablets 50 tablet (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
106003401000001112 Co-careldopa 25mg/100mg tablets 50 tablet en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

2 descendants. Search Descendants:

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Co-careldopa 25mg/100mg tablets 50 tablet Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Co-careldopa 25mg/100mg tablets 50 tablet Has VMP Co-careldopa 25mg/100mg tablets true Inferred relationship Existential restriction modifier
Co-careldopa 25mg/100mg tablets 50 tablet Has VMP Co-careldopa 25mg/100mg tablets false Inferred relationship Existential restriction modifier
Co-careldopa 25mg/100mg tablets 50 tablet Is a Virtual medicinal product pack true Inferred relationship Existential restriction modifier
Co-careldopa 25mg/100mg tablets 50 tablet Has VMP Product containing precisely carbidopa 25 milligram and levodopa 100 milligram/1 each conventional release oral tablet false Inferred relationship Existential restriction modifier
Co-careldopa 25mg/100mg tablets 50 tablet Has basis of strength substance Levodopa true Inferred relationship Existential restriction modifier 1
Co-careldopa 25mg/100mg tablets 50 tablet Has basis of strength substance Carbidopa true Inferred relationship Existential restriction modifier 2
Co-careldopa 25mg/100mg tablets 50 tablet Has presentation strength numerator value 100 false Inferred relationship Existential restriction modifier 1
Co-careldopa 25mg/100mg tablets 50 tablet Has presentation strength numerator value 25 false Inferred relationship Existential restriction modifier 2
Co-careldopa 25mg/100mg tablets 50 tablet Has presentation strength numerator unit milligram true Inferred relationship Existential restriction modifier 1
Co-careldopa 25mg/100mg tablets 50 tablet Has presentation strength numerator unit milligram true Inferred relationship Existential restriction modifier 2
Co-careldopa 25mg/100mg tablets 50 tablet Has presentation strength denominator value 1 false Inferred relationship Existential restriction modifier 1
Co-careldopa 25mg/100mg tablets 50 tablet Has presentation strength denominator value 1 false Inferred relationship Existential restriction modifier 2
Co-careldopa 25mg/100mg tablets 50 tablet Has presentation strength denominator unit Tablet true Inferred relationship Existential restriction modifier 1
Co-careldopa 25mg/100mg tablets 50 tablet Has presentation strength denominator unit Tablet true Inferred relationship Existential restriction modifier 2
Co-careldopa 25mg/100mg tablets 50 tablet VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Co-careldopa 25mg/100mg tablets 50 tablet VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Co-careldopa 25mg/100mg tablets 50 tablet Has specific active ingredient Levodopa true Inferred relationship Existential restriction modifier
Co-careldopa 25mg/100mg tablets 50 tablet Has specific active ingredient Carbidopa monohydrate true Inferred relationship Existential restriction modifier
Co-careldopa 25mg/100mg tablets 50 tablet Has dispensed dose form Tablet true Inferred relationship Existential restriction modifier
Co-careldopa 25mg/100mg tablets 50 tablet Has NHS dm+d (dictionary of medicines and devices) basis of strength substance Carbidopa true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Sinemet Plus 25mg/100mg tablets (Pilsco Ltd) 50 tablet Is a True Co-careldopa 25mg/100mg tablets 50 tablet Inferred relationship Existential restriction modifier
Co-careldopa 25mg/100mg tablets (Bristol Laboratories Ltd) 50 tablet 5 x 10 tablets Is a True Co-careldopa 25mg/100mg tablets 50 tablet Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start